- Home
- ZLAB vs STC Comparison
ZLAB vs STC Comparison
Compare ZLAB & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | STC |
|---|---|---|
| Founded | 2013 | 1893 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 1.9B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | STC |
|---|---|---|
| Price | $25.53 | $50.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $33.14 | ★ $82.25 |
| AVG Volume (30 Days) | ★ 713.1K | 261.6K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 4.27% |
| EPS Growth | 38.46 | ★ 55.17 |
| EPS | N/A | ★ 1.76 |
| Revenue | $460,156,000.00 | ★ $2,921,636,000.00 |
| Revenue This Year | N/A | $21.30 |
| Revenue Next Year | $26.50 | $9.22 |
| P/E Ratio | ★ N/A | $28.78 |
| Revenue Growth | 15.33 | ★ 17.32 |
| 52 Week Low | $15.96 | $48.74 |
| 52 Week High | $33.97 | $78.61 |
Technical Indicators
Market Signals| Indicator | ZLAB | STC |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 12.97 |
| Support Level | $24.81 | N/A |
| Resistance Level | $27.20 | $71.50 |
| Average True Range (ATR) | 0.77 | 1.94 |
| MACD | -0.03 | -1.48 |
| Stochastic Oscillator | 76.31 | 4.22 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments: Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.